Status:
COMPLETED
Effects of Therapeutic Mobile Game on Anxiety
Lead Sponsor:
Hunter College of City University of New York
Collaborating Sponsors:
Arcade Therapeutics Inc.
Conditions:
Social Anxiety Disorder
Eligibility:
All Genders
22-65 years
Phase:
NA
Brief Summary
Participants with Social Anxiety Disorder (SAD) will use a digital therapeutic for 30 days, and will complete assessments measuring a broad range of anxiety and mood-related symptoms, with a focus on ...
Detailed Description
This study aims to assess the feasibility and efficacy of the digital therapeutic ABM-01 in adults ages 22-65 with SAD. Participants access ABM-01 on their mobile smart phone and complete treatment ov...
Eligibility Criteria
Inclusion
- Adults 22-65 at the time of screening
- Meets DSM-5 diagnostic criteria for Social Anxiety Disorder
- Access to and willingness to use computer equipment/smartphone compatible with the product platform over a functional network for the study duration.
- Currently residing in the United States
Exclusion
- Risk of suicide or has attempted suicide within 24 months of the screening visit
- Moderate to severe substance use disorder
- Current co-morbid psychiatric diagnosis including PTSD, Schizophrenia, Bipolar Disorder I or II, Autism Spectrum Disorder, or Borderline Personality Disorder
- Currently pregnant or planning to become pregnant during the treatment period
Key Trial Info
Start Date :
June 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05240794
Start Date
June 15 2022
End Date
May 31 2023
Last Update
October 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hunter College of the City University of New York
New York, New York, United States, 10065